SAN DIEGO, Calif., July 14, 2022 (GLOBE NEWSWIRE) — Trans NewMediaWire – Medical marijuana, Inc. (OTC: MJNA) (“the Company”), the first publicly traded cannabis company in the United States that launched the first cannabis-derived products, brands, and supply chain, today announced that its subsidiary HempMeds® Brasil Created a new podcast focused on health and wellness PodioCast As a result, it has been featured in several prominent news publications in Brazil such as Globo’s Galileu (pictured below), sports lifeand the Desobediência Produtiva podcast.
PodioCast is hosted by Actress and Presenter Rachel Apollonio, CEO of HempMeds® Brasil, Matheus Batelli, and veteran journalist and HempMeds® Marketing Specialist Marcus Bruno. Each episode features interviews with athletes and medical professionals to talk about the wellness challenges and routines of top athletes and active consumers.
“The mission of our podcast is to help break the stigma of CBD and cannabis and educate people on how to incorporate it into their lives,” said Mateus Batelli, CEO of HempMeds® Brasil. “We’ve already been able to exclusively interview a variety of influential X Games winners, MMA and Boxing world champions, and other Olympic medalists, and these articles have been a huge help for us to promote the podcast.”
In addition to the podcast, these articles talk about how the World Anti-Doping Agency (WADA) removed CBD from its list of banned substances in 2018 and since then more athletes, both professional and amateur, in Brazil have started using CBD products. Biologicals, such as those offered by HempMeds®.
They also highlight how HempMeds® has been dedicated to educating patients and clinicians about cannabidiol (CBD) since the company’s inception. HempMeds educational initiatives include online academic resources, in-person training courses and virtual medical training courses to train clinicians in cannabinoid therapies and discuss principles of the human endocannabinoid system, global CBD sponsorship and condition-specific seminars aimed at assisting patients in the legal field. Guidelines and finding doctors and financial support.
“We are thrilled to be pioneering the introduction of non-psychoactive cannabis to Brazil. We hope enthusiasts across Brazil will join the podcast to learn more and play a role in our movement,” said Blake Schroeder, CEO of Medical Marijuana. That the new HempMeds podcast is a testament to our mission to provide free and informed access to CBD around the world.”
To learn more about HempMeds® Brasil, please visit www.hempmeds.com.br.
About HempMeds® Brasil
HempMeds® Brasil was the first company to obtain approval from the National Health Surveillance Agency (Anvisa) to import a product based on cannabidiol, a substance derived from cannabis, a plant of the genus Cannabis. Currently, it is authorized to supply its products that help control diseases such as epilepsy, Parkinson’s disease, chronic pain, and multiple sclerosis, by prescription. For these indications, the products can be subsidized by the Brazilian government. HempMeds® Brasil is working on additional approvals for other indications. www.hempmeds.com.br.
About Medical Marijuana, Inc.
We are Firsts®. Medical marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabis space: a global portfolio of hemp-based nutritional brands led by Kanawee® And HempMeds®; leader in sourcing high quality, legal, non-psychoactive cannabis products derived from industrial hemp; and the cannabis-based clinical research and plant-based drug development segment led by pharmaceutical investment firms and their partners incl AXIM® Biotechnologies, Inc. And Neurobatics. Medical Marijuana, Inc. As the best CBD product by CNBC. Medical Marijuana, Inc. Also the first company to obtain historical import authorizations for CBD products from the governments of Brazil, Mexico, Argentina and Paraguay and is a leader in the development of international markets. The company’s main product Real scientific hemp oil It has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.
Medical Marijuana, Inc. is headquartered in In San Diego, California, additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. Watch the Medical Marijuana, Inc. video. , click here.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934, and is subject to the safe harbor laws established by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and are subject to risks and uncertainties. These forward-looking statements by definition involve risks, uncertainties and other factors that could cause the actual results, performance or achievements of Medical Marijuana, Inc. to differ. materially from the data presented here.
Disclosure to the Food and Drug Administration (FDA)
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Medical Marijuana, Inc. does not sell or distribute any products that violate the US Controlled Substances Act.
Investor Relations Contact:
P. (858) 283-4016